Long‐term macrolides for non‐cystic fibrosis bronchiectasis: A systematic review and meta‐analysis

@article{Wu2014LongtermMF,
  title={Long‐term macrolides for non‐cystic fibrosis bronchiectasis: A systematic review and meta‐analysis},
  author={Qibiao Wu and W. Shen and H. Cheng and Xiqiao Zhou},
  journal={Respirology},
  year={2014},
  volume={19}
}
Long‐term macrolides are increasingly being prescribed for stable bronchiectasis. This meta‐analysis assessed the clinical effect of this treatment in bronchiectasis. A systematic review and meta‐analysis were carried out. All randomized, controlled trials (RCT) comparing long‐term macrolides with placebo and/or usual medical care, with outcome measures relating to efficacy and safety were selected. Nine RCT recruiting 530 patients were included. Compared with placebo and/or usual medical care… Expand
60 Citations
Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use
Head-to-head trials of antibiotics for bronchiectasis.
Management of bronchiectasis in adults
Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Long-term macrolide therapy in chronic inflammatory airway diseases
Long‐term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments
A pilot study of low-dose erythromycin in bronchiectasis.
[Impact of treatment with low dose roxithromycin on stable bronchiectasis].
  • Jifeng Liu, X. Zhong, +4 authors W. Zhong
  • Medicine
  • Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
  • 2012
Quality of life and inflammation in exacerbations of bronchiectasis
...
1
2
3
4
5
...